<DOC>
	<DOC>NCT00808314</DOC>
	<brief_summary>Lexiscan(TM) has ideal properties for Rb-82 PET imaging and the stress response it invokes may offer multiple advantages for the diagnosis of coronary disease and functional abnormalities. The goal of this investigation is to establish quantitative equivalence of Lexiscan(TM) rest/stress Rb-82 PET images to dipyridamole rest/stress images.</brief_summary>
	<brief_title>Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<criteria>BMI &lt;35 No intervention or change in management between dipyridamole and Lexiscan(TM) PET BMI &gt;35 An intervention or change in management between dipyridamole and Lexiscan(TM) PET</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Lexiscan(TM)</keyword>
	<keyword>Dipyridamole</keyword>
	<keyword>Myocardial Perfusion</keyword>
	<keyword>Positron Emission Computed Tomography</keyword>
</DOC>